【摘要】 目的探讨头孢地尼联合奥硝唑治疗盆腔炎的疗效。方法选取无锡市锡山人民医院/东南大学附属中大医院无锡分院妇产科2014年4月~2015年8月治疗的确诊为盆腔炎患者的患者共60例,按随机数字表发分为观察组和对照组各30例,对照组给予奥硝唑治疗,观察组患者给予奥硝唑治疗的基础上给予头孢地尼治疗,治疗14 d后随访并记录2组患者C-反应蛋白、血液流变学、临床疗效的对比情况,采用统计学方法对数据进行分析。结果治疗2周后,观察组IL-1、C-反应蛋白值分别为(20.65±7.91pg/m L、11.62±4.58 mg/L),均优于对照组(34.54±13.72 pg/m L、17.08±5.01 mg/L)(P<0.05);治疗2周后,观察组血浆黏度、红细胞压积值分别为(1.12±0.26 mpass.s、0.39±0.07%),均优于对照组(1.59±0.28mpass.s、0.48±0.09%)(P<0.05);治疗2周后观察组患者总有效率达(90.0%)明显高于对照组(66.67%)(P<0.05)。结论头孢地尼联合奥硝唑治疗盆腔炎的效果良好,优于单独运用奥硝唑药物。更多还原

【Abstract】 Objective To explore clinical effect of Cefdinir combined with Omidazole in treatment of pelvic inflammatory disease. Methods 60 cases of pelvic inflammatory disease from April 2014 to August 2015,were randomly divided into two groups and 30 cases in each group. Control group were given Ornidazole basic treatment,observation group were given Omidazole treatment given Cefdinir treatment on the basis of control group,after treated for 14 d,patients were followed up and recorded C-reactive protein, blood rheology, compared clinical efficacy by statistical methods.Results After 2 weeks of treatment,observation group C- reactive protein value of( 4. 11 ± 1. 45) mg / L,lower than control group( 7. 63 ± 1. 57) mg / L( P < 0. 05). After 2 weeks of treatment,observation group plasma viscosity,hematocrit values were( 1. 12 ± 0. 26) mpass·s,( 0. 39 ± 0. 07) %,than control group( 1. 59 ± 0. 28) mpass·s,( 0. 48 ± 0. 09) %( P < 0. 05). After 2 weeks of treatment of patients in observation group total effective rate was 90. 00%,significantly higher than 66. 67%( P < 0. 05). Conclusion It is good for Cefdinir combined with Omidazole in treatment of pelvic inflammatory disease better than Ornidazole medication use alone is worthy of further research and application.更多还原